Labrador, Rejievhan .

HRN: 22-59-95  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/21/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/21/2023
03/02/2023
IV
240mg
Q8
Intestinal Amoebiasis
Waiting Final Action 
02/21/2023
CEFTRIAXONE 1G (VIAL)
02/21/2023
02/28/2023
IVT
1.5g
Q24
Sepsis
Waiting Final Action 
02/22/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/22/2023
03/01/2023
IV
217
Q24h
Sepsis
Waiting Final Action 
02/22/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/22/2023
03/01/2023
IV
1 G
Q6
Sepsis
Waiting Final Action 
02/25/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/25/2023
03/03/2023
IVT
150mg
Q8
Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: